IP Library Granted Patent US 10,179,902
Granted Patent B2
US 10,179,902 · App. 15/654,624 · Granted Jan 15, 2019

Methods of making human primitive ectoderm cells

Inventors: Kevin Allen D'Amour (San Diego, CA); Alan D. Agulnick (San Diego, CA); Susan Eliazer (Moraga, CA); Evert Kroon (San Diego, CA); Emmanuel E. Baetge (Encinitas, CA)
Assignee: ViaCyte, Inc.
C12N5/0606C12N5/0603C12N2500/90C12N2501/115C12N2501/155C12N2501/16C12N2506/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,902
App. No.
15/654,624
Granted
Jan 15, 2019
Kind
B2
Abstract

This disclosure relates to compositions comprising human preprimitive streak cells and/or human mesendoderm cells as well as methods for their production. Additionally, disclosed herein are methods of identifying factors useful in the further differentiation of preprimitive streak and mesendoderm cell types.

Claims (19)

1. An in vitro method of producing human primitive ectoderm cells, comprising the steps of:

(a) providing a cell population comprising human pluripotent stem cells, and

(b) culturing the human pluripotent stern cells with a(least 100 ng/ml activin A to promote differentiation of the human pluripotent stem cells to human primitive ectoderm cells, said human primitive ectoderm cells are multipotent cells that can differentiate into human mesoderm or human definitive endoderm cells;

thereby producing human primitive ectoderm cells.

2. The method of claim 1 , wherein the human pluripotent stem cells are further cultured with Nodal or activin B.

3. The method of claim 1 , wherein the human pluripotent stem cells comprise human embryonic stem cells.

4. The method of claim 1 , wherein the human pluripotent stem cells are derived from a morula, an inner cell mass (ICM) of an embryo or gonadal ridges of an embryo.

5. The method of claim h further comprising the step of providing serum to the human pluripotent stem cells.

6. The method of claim h further comprising providing a medium that comprises less than 2% (v/v) serum to the human pluripotent stem cells.

7. The method of claim 1 , wherein the population of human primitive ectoderm cells express FZD10, FGF5 or OCT4.

8. The method of claim 1 , wherein at least 15% of the pluripotent human stem cells differentiate into the human primitive ectoderm cells.

9. The method of claim 1 , wherein at least 50% of the pluripotent human stem cells differentiate into the human primitive ectoderm cells.

10. The method of claim 1 , wherein at least 90% of the pluripotent human stem cells differentiate into the human primitive ectoderm cells.

11. An in vitro method of producing a cell population comprising at least 10% human primitive ectoderm cells, comprising the steps of:

(a) providing a cell population comprising human pluripotent stem cells, and

(b) culturing the human pluripotent stem cells with at least 100 ng/ml activin A to promote differentiation of the human pluripotent stem cells to human primitive ectoderm cells, said human primitive ectoderm cells are multipotent cells that can differentiate into human mesoderm or human definitive endoderm cells;

thereby generating the cell population comprising at least 10% human primitive ectoderm cells.

12. The method of claim 11 , wherein the cell population is cultured in a medium that does not comprise serum.

13. The method of claim 11 , wherein the cell population is cultured in a medium that does not comprise serum replacement.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2017
From: D'AMOUR, KEVIN ALLEN; AGULNICK, ALAN D.; ELIAZER, SUSAN; KROON, EVERT; BAETGE, EMMANUEL E.
To: CYTHERA, INC.
Reel/Frame 043491/0983 →
MERGER AND CHANGE OF NAME Recorded Sep 5, 2017
From: CYTHERA, INC.; VIACYTE, INC.
To: VIACYTE, INC.
Reel/Frame 043492/0010 →
Continuity (9)
Continuation 13190390 · Jul 25, 2011
Continuation 11474211 · Jun 23, 2006
Continuation PCTUS2005024161 · Jul 8, 2005
Continuation In Part 11021618 · Dec 23, 2004
Provisional Application 60693364 · Jun 23, 2005
Provisional Application 60587942 · Jul 14, 2004
Provisional Application 60586566 · Jul 9, 2004
Provisional Application 60532004 · Dec 23, 2003
Related Publication 20170313979A1 · Nov 2, 2017